TABLE 5.
Tetrameric complexes used
| Tetramer specificity | HLA restriction | Virus | Protein | Sequence | Amino acid positions |
|---|---|---|---|---|---|
| hCMV-pp65 | HLA-A*0101 | hCMV | pp65 | YSEHPTFTSQY | 363–373 |
| HLA-A*0201 | hCMV | pp66 | NLVPMVATV | 495–504 | |
| HLA-B*0702 | hCMV | pp65 | TPRVTGGGAM | 417–426 | |
| HLA-B*3501 | hCMV | pp65 | IPSINVHHY | 123–131 | |
| EBV-BZLF1 | HLA-B*3501 | EBV | BZLF-1 | EPLPQGQLTAY | 64–65 |
| EBV-BMLF1 | HLA-A*0201 | EBV | BMLF-1 | GLCTLVAML | 259–267 |
| EBV-EBNA1 | HLA-B*3501 | EBV | EBNA1 | HPVGEADYFEY | 407–417 |
| EBV-EBNA3a | HLA-B*0702 | EBV | EBNA3a | RPPIFIRRL | 247–255 |
| HLA-B*0802 | EBV | EBNA3a | FLRGRAYGL | 193–201 | |
| HLA-A*0301 | EBV | EBNA3a | RLRAEAQVK | 603–611 | |
| FLU-MP | HLA-A*0201 | Influenza A virus | Matrix protein 1 | GILGFVFTL | 58–66 |
| RSV-NP | HLA-B*0702 | RSV | Nucleoprotein | NPKASLLSL | 306–314 |
| HIV-gag | HLA-B*0802 | HIV | Gag (p24) | EIYKRWII | 260–267 |
| HIV-nef | HLA-B*0802 | HIV | Nef | FLKEKGGL | 90–97 |